Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice.
A reverse genetic system was recently established for the coronavirus mouse hepatitis virus strain A59 (MHV-A59), in which cDNA fragments of the RNA genome are assembled in vitro into a full-length genome cDNA, followed by electroporation of in vitro-transcribed genome RNA into cells with recovery of viable virus. The "in vitro-assembled" wild-type MHV-A59 virus (icMHV-A59) demonstrated replication identical to laboratory strains of MHV-A59 in tissue culture; however, icMHV-A59 was avirulent following intracranial inoculation of C57BL/6 mice. Sequencing of the cloned genome cDNA fragments identified two single-nucleotide mutations in cloned genome fragment F, encoding a Tyr6398His substitution in open reading frame (ORF) 1b p59-nsp14 and a Leu94Pro substitution in the ORF 2a 30-kDa protein. The mutations were repaired individually and together in recombinant viruses, all of which demonstrated wild-type replication in tissue culture. Following intracranial inoculation of mice, the viruses encoding Tyr6398His/Leu94Pro substitutions and the Tyr6398His substitution alone demonstrated log10 50% lethal dose (LD50) values too great to be measured. The Leu94Pro mutant virus had reduced but measurable log10 LD5), and the "corrected" Tyr6398/Leu94 virus had a log10 LD50 identical to wild-type MHV-A59. The experiments have defined residues in ORF 1b and ORF 2a that attenuate virus replication and virulence in mice but do not affect in vitro replication. The results suggest that these proteins serve roles in pathogenesis or virus survival in vivo distinct from functions in virus replication. The study also demonstrates the usefulness of the reverse genetic system to confirm the role of residues or proteins in coronavirus replication and pathogenesis.
Sperry
Steven M
SM
Department of Pediatrics, Vanderbilt University Medical Center, D6217 MCN, Nashville, TN 37232-2581, USA.
Kazi
Lubna
L
Graham
Rachel L
RL
Baric
Ralph S
RS
Weiss
Susan R
SR
Denison
Mark R
MR
D019943:Amino Acid Substitution; D000818:Animals; D018352:Coronavirus Infections / Q000821:virology*; D018076:DNA, Complementary; D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics; D004195:Disease Models, Animal; D051379:Mice; D008969:Molecular Sequence Data; D006517:Murine hepatitis virus / Q000235:genetics* / Q000472:pathogenicity*; D016366:Open Reading Frames; D017422:Sequence Analysis, DNA; D017361:Viral Nonstructural Proteins / Q000737:chemistry / Q000235:genetics* / Q000502:physiology; D010948:Viral Plaque Assay; D014774:Virulence / Q000235:genetics; D014779:Virus Replication
D018076:DNA, Complementary; D004279:DNA, Viral; D017361:Viral Nonstructural Proteins
J Virol. 2000 Feb;74(3):1393-406
10627550
Virology. 1997 Apr 14;230(2):335-42
9143289
J Virol. 2000 Oct;74(19):9206-13
10982367
J Virol. 2001 Mar;75(5):2452-7
11160748
J Reprod Immunol. 2001 Apr;50(1):19-40
11254939
Exp Mol Pathol. 2001 Aug;71(1):1-12
11502093
Virology. 1997 Jul 7;233(2):260-70
9217050
Virology. 1997 Dec 8;239(1):1-10
9426441
J Virol. 1999 Sep;73(9):7752-60
10438865
J Neurovirol. 2001 Oct;7(5):432-6
11582515
Virology. 2001 Oct 25;289(2):230-8
11689046
Virology. 1995 Apr 1;208(1):1-8
11831690
J Virol. 2002 Jun;76(12):5937-48
12021326
Virology. 2002 Apr 25;296(1):177-89
12036329
Nat Med. 2002 Sep;8(9):950-4
12195436
J Virol. 2002 Nov;76(21):11065-78
12368349
J Virol. 2003 Apr;77(8):4972-8
12663803
Virology. 2003 Mar 30;308(1):13-22
12706086
Cell. 2003 Jun 13;113(6):803-9
12809610
J Mol Biol. 2003 Aug 29;331(5):991-1004
12927536
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000
14569023
Virology. 2004 Jan 5;318(1):381-92
14972563
J Biol Chem. 2004 Mar 12;279(11):10136-41
14699140
J Virol. 2004 Apr;78(8):4363-9
15047850
J Virol. 2004 Jun;78(11):5957-65
15140993
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12694-9
15304651
EMBO J. 1983;2(10):1839-44
6196191
Neurology. 1984 May;34(5):597-603
6324031
Virology. 1987 Apr;157(2):509-15
3029985
Virology. 1987 Dec;161(2):479-87
2825419
Virology. 1988 Oct;166(2):415-22
2845655
J Virol. 1989 Sep;63(9):3729-36
2547994
Virology. 1990 Feb;174(2):605-7
2154893
Virology. 1990 Mar;175(1):303-6
2155511
J Neurovirol. 2001 Oct;7(5):421-31
11582514
Nucleic Acids Res. 1990 Apr 11;18(7):1825-32
2159623
J Virol. 1990 Oct;64(10):4784-91
2168966
Virology. 1991 Feb;180(2):567-82
1846489
J Virol. 1991 Oct;65(10):5605-8
1654456
J Virol. 1992 Apr;66(4):1841-8
1312608
Arch Virol. 1993;129(1-4):301-9
8385918
Virology. 1994 Feb;198(2):736-40
8291254
Virology. 1994 Apr;200(1):1-10
8128613
Adv Exp Med Biol. 1993;342:157-63
8209723
Virology. 1994 Aug 1;202(2):621-30
8030227
Virology. 1995 Dec 1;214(1):128-38
8525608
EMBO J. 2000 Sep 1;19(17):4701-11
10970862